Reducing exposure to high-risk triggers, particularly in early recovery, reduces craving frequency and intensity
Pharmaceutical interventions are usually designed to reduce food intake by manipulating appetite
However, after adjusting for key clinical confounders, the association between PAGln and GRACE score was no longer statistically significant, suggesting that the observed correlation may be substantially influenced or confounded by age and renal function
In good agreement, intervention with the multi-agonists significantly reduced food intake from 2- to 72-h, while the anorectic effects of GLP1 manifested only from 2- to 24-h (Suppl
(2025) 1 Introduction Glyoxalase 1 (GLO-1) is a key enzyme in the glyoxalase system, catalyzing the conversion of methylglyoxal (MG) into S-D-lactoylglutathione, thereby mitigating the formation of advanced glycation end products (AGEs)
Metab Eng 61:160170